CIK 0001770787
- Large accelerated filer
10x Genomics, Inc.
Sign in to watch- Ticker
- TXG
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 455614458
- Phone
- +1 925-401-7300
- Business address
- 6230 STONERIDGE MALL ROAD, PLEASANTON, CA, 94588
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,605,538
- in 10 filings, $6.3M under 10b5-1 plans
Net −$12,605,538. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-02 | Hindson Benjamin J. Director | Sale | −10,713 | $180.13 | $1.9M | 64,454 |
| 2021-08-02 | Hindson Benjamin J. Director | Sale | −8,800 | $181.13 | $1.6M | 55,654 |
| 2021-08-02 | Hindson Benjamin J. Director | Sale | −5,200 | $181.98 | $946K | 50,454 |
| 2021-08-02 | Hindson Benjamin J. Director | Sale | −1,800 | $183.02 | $329K | 48,654 |
| 2021-08-02 | Hindson Benjamin J. Director | Sale | −800 | $184.02 | $147K | 47,854 |
| 2021-08-02 | Hindson Benjamin J. Director | Sale | −400 | $184.95 | $74K | 47,454 |
| 2021-08-02 | Hindson Benjamin J. Director | Exercise or conversion · Stock Option (right to buy) | −11,114 | 59,968 | ||
| 2021-08-02 | Hindson Benjamin J. Director | Exercise or conversion · Stock Option (right to buy) | −30,552 | 144,448 | ||
| 2021-07-23 | Kosaraju Sridhar Director | Sale | −459 | $182.32 | $84K | 11,541 |
| 2021-07-23 | Kosaraju Sridhar Director | Sale | −400 | $183.07 | $73K | 11,141 |
| 2021-07-23 | Kosaraju Sridhar Director | Sale | −400 | $184.43 | $74K | 10,741 |
| 2021-07-23 | Kosaraju Sridhar Director | Sale | −241 | $185.96 | $45K | 10,500 |
| 2021-07-16 | STUELPNAGEL JOHN R Director | Sale | −500 | $168.57 | $84K | 396,116 |
| 2021-07-16 | STUELPNAGEL JOHN R Director | Sale | −1,710 | $169.75 | $290K | 394,406 |
| 2021-07-16 | STUELPNAGEL JOHN R Director | Sale | −2,190 | $170.83 | $374K | 392,216 |
| 2021-07-16 | STUELPNAGEL JOHN R Director | Sale | −600 | $171.44 | $103K | 391,616 |
| 2021-07-12 | CRUTCHFIELD BRADFORD Chief Commercial Officer | Exercise or conversion | +17,000 | $1.16 | $20K | 60,606 |
| 2021-07-12 | CRUTCHFIELD BRADFORD Chief Commercial Officer | Sale | −5,755 | $185.07 | $1.1M | 54,851 |
| 2021-07-12 | CRUTCHFIELD BRADFORD Chief Commercial Officer | Sale | −4,400 | $185.87 | $818K | 50,451 |
| 2021-07-12 | CRUTCHFIELD BRADFORD Chief Commercial Officer | Sale | −3,933 | $187.31 | $737K | 46,518 |
Page 30 of 57 · 1,128 trades